Search

everythinglearnresearchcommunity

for

Search:↓

Genes and hormones cause hair loss, with four genes contributing equally.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Male skin gets drier and more alkaline as it ages, which may need different skincare than women's skin.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

SHBG binding properties are unchanged in male liver cirrhosis patients.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.